Patents by Inventor Magnus Ronn

Magnus Ronn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SALTS AND CRYSTAL FORMS OF GABA-A POSITIVE ALLOSTERIC MODULATOR
    Publication number: 20240140985
    Abstract: The invention relates to salts of Compound 1, crystalline forms thereof, methods of their preparation, pharmaceutical compositions thereof and methods of their use
    Type: Application
    Filed: December 5, 2023
    Publication date: May 2, 2024
    Applicant: Praxis Precision Medicines, Inc.
    Inventors: Nelson B. OLIVIER, Kiran REDDY, Gabriel Martinez Botella, Magnus RONN, Paul A. LASKAR
  • CRYSTALLINE FORMS OF 3-(5-(2-HYDROXY-2-METHYLPROPOXY)-6-METHYLPYRAZIN-2-YL)-1H-INDOLE-7-CARBONITRILE
    Publication number: 20230257361
    Abstract: This disclosure provides crystalline forms of an androgen receptor modulator, and methods of making and using these forms.
    Type: Application
    Filed: January 13, 2023
    Publication date: August 17, 2023
    Inventors: Bakary-Barry TOURE, Magnus RONN
  • CRYSTALLINE FORMS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF
    Publication number: 20230192679
    Abstract: Crystalline forms and pharmaceutical composition of a PRMT5 inhibitor of formula (I), methods of making PRMT5 inhibitor of formula (I) and crystalline forms thereof, methods of making the pharmaceutical compositions of the PRMT5 inhibitor of formula (I) and methods of using the PRMT5 inhibitor of formula (I) or crystalline solid forms and pharmaceutically acceptable compositions thereof.
    Type: Application
    Filed: December 16, 2022
    Publication date: June 22, 2023
    Inventors: Kevin M. Cottrell, Sapna Makhija Garad, Magnus Ronn, Kimberly Jane Briggs, Erik William Wilker, Matthew Robert Tonini, Minjie Zhang, Alice Wanjung Tsai-Marie, Jianglin Liang, Hongming Li
  • SALTS AND CRYSTAL FORMS OF GABA-A POSITIVE ALLOSTERIC MODULATOR
    Publication number: 20220024967
    Abstract: The invention relates to salts of Compound 1, crystalline forms thereof, methods of their preparation, pharmaceutical compositions thereof and methods of their use
    Type: Application
    Filed: January 7, 2021
    Publication date: January 27, 2022
    Inventors: Nelson B. OLIVIER, Kiran REDDY, Gabriel Martinez BOTELLA, Magnus RONN, Paul A. LASKAR
  • Salts and crystal forms of GABApositive allosteric modulator
    Patent number: 10927141
    Abstract: The invention relates to salts of Compound 1, crystalline forms thereof, methods of their preparation, pharmaceutical compositions thereof and methods of their use.
    Type: Grant
    Filed: November 27, 2019
    Date of Patent: February 23, 2021
    Assignee: PRAXIS PRECISION MEDICINES, INC.
    Inventors: Nelson B. Olivier, Kiran Reddy, Gabriel Martinez Botella, Magnus Ronn, Paul A. Laskar
  • SALTS AND CRYSTAL FORMS OF GABA-A POSITIVE ALLOSTERIC MODULATOR
    Publication number: 20200255471
    Abstract: The invention relates to salts of Compound 1, crystalline forms thereof, methods of their preparation, pharmaceutical compositions thereof and methods of their use
    Type: Application
    Filed: November 27, 2019
    Publication date: August 13, 2020
    Inventors: Nelson B. OLIVIER, Kiran REDDY, Gabriel Martinez BOTELLA, Magnus RONN, Paul A. LASKAR
  • SALTS AND CRYSTAL FORMS OF GABA-A POSITIVE ALLOSTERIC MODULATOR
    Publication number: 20200071350
    Abstract: The invention relates to salts of Compound 1, crystalline forms thereof, methods of their preparation, pharmaceutical compositions thereof and methods of their use
    Type: Application
    Filed: July 19, 2019
    Publication date: March 5, 2020
    Inventors: Nelson B. OLIVIER, Kiran REDDY, Gabriel Martinez BOTELLA, Magnus RONN, Paul A. LASKAR
  • Salts and crystal forms of GABApositive allosteric modulator
    Patent number: 10562930
    Abstract: The invention relates to salts of Compound 1, crystalline forms thereof, methods of their preparation, pharmaceutical compositions thereof and methods of their use.
    Type: Grant
    Filed: July 19, 2019
    Date of Patent: February 18, 2020
    Assignee: PRAXIS PRECISION MEDICINES, INC.
    Inventors: Nelson B. Olivier, Kiran Reddy, Gabriel Martinez Botella, Magnus Ronn, Paul A. Laskar
  • Polycyclic tetracycline compounds
    Patent number: 9371283
    Abstract: The present invention is directed to a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (I) are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula (I) and its therapeutic use.
    Type: Grant
    Filed: March 30, 2011
    Date of Patent: June 21, 2016
    Assignee: Tetraphase Pharmaceuticals, Inc.
    Inventors: Xiao-Yi Xiao, Roger Clark, Diana Hunt, Magnus Rönn, Louis Plamondon, Minsheng He, Joyce Sutcliffe, Trudy Grossman
  • Tetracycline compounds
    Patent number: 9315451
    Abstract: The present invention is directed to a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula I are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula I and its therapeutic use.
    Type: Grant
    Filed: May 7, 2010
    Date of Patent: April 19, 2016
    Assignee: TETRAPHASE PHARMACEUTICALS, INC.
    Inventors: Chi-Li Chen, Roger B. Clark, Yonghong Deng, Minsheng He, Louis Plamondon, Cuixiang Sun, Xiao-Yi Xiao, Magnus Rönn
  • Tetracycline Compounds
    Publication number: 20120135968
    Abstract: The present invention is directed to a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula I are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula I and its therapeutic use.
    Type: Application
    Filed: May 7, 2010
    Publication date: May 31, 2012
    Inventors: Chi-Li Chen, Roger B. Clark, Yonghong Deng, Minsheng He, Louis Plamondon, Cuixiang Sun, Xiao-Yi Xiao, Magnus Rönn
  • Polycyclic Tetracycline Compounds
    Publication number: 20110269714
    Abstract: The present invention is directed to a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (I) are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula (I) and its therapeutic use.
    Type: Application
    Filed: March 30, 2011
    Publication date: November 3, 2011
    Applicant: Tetraphase Pharmaceuticals, Inc.
    Inventors: Xiao-Yi Xiao, Roger Clark, Diana Hunt, Magnus Rönn, Louis Plamondon, Minsheng He, Joyce Sutcliffe, Trudy Grossman